Navigation Links
MicroConstants China Signs Site Management Organization Agreement with the Clinical Research Center of No. 307 Hospital

BEIJING, Jan. 28, 2013 /PRNewswire/ -- MicroConstants China Inc., a Contract Research Organization (CRO) conducting preclinical pharmacokinetic studies, early-stage clinical trials, and regulated bioanalysis in China, has signed a strategic collaboration agreement with the clinical research center of the No. 307 Hospital of People's Liberation Army to provide site management services. The agreement designates MicroConstants China as No. 307 Hospital's official site management organization (SMO).

Over the past three years, MicroConstants China has worked closely with the Phase I unit of No. 307 Hospital to implement quality systems and procedures that comply with International Conference on Harmonization Good Clinical Practice (ICH GCP) guidelines. This has included developing standard operating procedures (SOP), training clinical site personnel, performing quality assurance (QA) audits, installing a clinical trial information management system (CTIMS), and obtaining SIDCER Recognition from the Forum for Ethical Review Committees in the Asian and Western Pacific Region (FERCAP).

"Through our collaboration with MicroConstants China, we have learned the true meaning of GCP compliance in daily practice and are now capable of identifying deficiencies and coming up with corrective actions to address them," said Dr. Zeyuan Liu , director of the clinical pharmacology unit at No. 307 Hospital. "Working with MicroConstants China enabled us to improve our quality system in a short period of time and effectively win contracts from major global pharmaceutical companies."

"The execution of this strategic collaboration agreement verifies our achievements and is an important step for our SMO business," said Dr. Q. David Yang , chief executive officer of MicroConstants China. "Our goal is to implement ICH GCP compliant quality systems for more clinical trial centers in China so their clinical trial data can be submitted directly to the United States Food and Drug Administration (FDA) and the European Medicines Agency (EMA) for approval."

About the No. 307 Hospital Clinical Research Center
Established in 1957, the No. 307 Hospital of People's Liberation Army is among the top tier hospitals in China with 38 specialty groups and over 1,100 beds. Their clinical trial center is certified by the SFDA for Phase I clinical studies and Phase II/III/IV clinical studies for cancer, hematology, anti-radiation, detoxification, and anti-dependency drugs. The clinical research center has conducted clinical trials for more than 200 sponsors, including eight of the top ten global pharmaceutical companies.

About MicroConstants China Inc.
MicroConstants China Inc. is a Contract Research Organization (CRO) that was established in 2007 by the founder and president of MicroConstants, Inc., a bioanalytical and DMPK specialty CRO in San Diego, California with over a decade of GLP compliance history. Located in Beijing, MicroConstants China conducts preclinical and clinical pharmacokinetic studies, provides regulated bioanalysis and analytical services, and offers early-stage clinical trial management services and quality system consulting. For more information, please visit

SOURCE MicroConstants China Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. China Botanic Appoints Jack Zhao as Independent Director
2. Dental Radiology Equipment Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018
3. Dental Lasers Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018
4. Respiratory Disposables Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018
5. The 1st China International Dental CAD/CAM Forum to Be Held in DenTech China 2013
6. Perceptive Informatics Opens First Customer Care Office in China
7. Affluence, an Aging Population, and Anticipated Rx-to-OTC Switches Boost a Healthy $32 Billion OTC Market in China, According to Kline
8. Government Investments in Upgrades Sustain Laboratory Analytical Instrumentation Market in China, Finds Frost & Sullivan
9. Medical Device Market Updates: IVD and Ophthalmic Devices Dominate Chinas $30.5 bn Medical Device Market; Invisible Hearing Aids Set to Make Big Noise
10. Sihuan Pharmaceutical Collaborates with NeuroVive to Develop Two Innovative Cardio-cerebral Vascular Products in China
11. DenTech China 2012 Closed with Success
Post Your Comments:
(Date:6/24/2016)... ALEXANDRIA, Va. , June 24, 2016 ... a set of recommendations that would allow ... information (HCEI) with entities that make formulary and coverage ... determine the "value" of new medicines. The ... that does not appear on the drug label, a ...
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ... company developing innovative inhaled drugs, announced today that it ... Russell Investments reconstituted its comprehensive set of U.S. ... "This is an important milestone for Pulmatrix," said ... increase shareholder awareness of our progress in developing drugs ...
(Date:6/23/2016)... BEVERLY HILLS, Calif. , June 23, 2016 ... faced the many challenges of the current process. Many of ... option because of the technical difficulties and high laboratory costs ... would have to offer it at such a high cost ... to afford it. Dr. Parsa Zadeh , ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... 26, 2016 , ... Brent Kasmer, a legally blind and certified personal trainer is helping to ... app. The fitness app plans to fix the two major problems leading the fitness industry ... fits all type program , They don’t eliminate all the reasons people quit ...
(Date:6/25/2016)... D.C. (PRWEB) , ... June 25, 2016 , ... ... discuss health policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, ... their work on several important health care topics including advance care planning, healthcare ...
(Date:6/25/2016)... ... 2016 , ... The temporary closing of Bruton Memorial Library on June 21 due to a ... new, often overlooked aspect of head lice: the parasite’s ability to live away from a ... occurrence, but a necessary one in the event that lice have simply gotten out of ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency ... named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director ...
(Date:6/25/2016)... Oklahoma (PRWEB) , ... June 25, 2016 , ... ... both athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures ... Oklahoma City area —Johnson is one of the first doctors to perform the ...
Breaking Medicine News(10 mins):